Laverock Therapeutics has been confirmed as the latest tenant to take space at London BioScience Innovation Centre at the Apex in King’s Cross. N1.
The gene silencing technology company has signed a five-year lease for 4,133 sq
Second occupier confirmed at London BioScience Innovation Centre
